Author correction to “Cerium single-atom catalysts-armed Lactobacillus reuteri for multipronged anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease” [Acta Pharmaceutica Sinica B 15 (2025) 5400-5415]

Authors

Han Lin (ORCID: https://orcid.org/0000-0003-1663-5468)
Wenhao Li (ORCID: https://orcid.org/0000-0003-4170-4736)
Yinying Pu
Kun Zhang (ORCID: https://orcid.org/0000-0002-6971-1164)
Shuang Gao (ORCID: https://orcid.org/0000-0003-0300-6857)
Shaorong Huang (ORCID: https://orcid.org/0009-0009-0801-3555)
Qiyue Li (ORCID: https://orcid.org/0000-0002-2342-4477)
Min Zhou (ORCID: https://orcid.org/0000-0003-2809-809X)
Yangying Duan (ORCID: https://orcid.org/0000-0002-1768-5291)
W.Z. Wu (ORCID: https://orcid.org/0009-0002-8850-2162)

Institutions

Tongji University (CN)
Chinese Academy of Sciences (CN)
First Affiliated Hospital of Jiangxi Medical College (CN)
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
Shanghai Institute of Ceramics (CN)

Publication Details

Journal: Acta Pharmaceutica Sinica B
Published: 2025-12-01
DOI: https://doi.org/10.1016/j.apsb.2025.12.001
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Author correction to “Cerium single-atom catalysts-armed Lactobacillus reuteri for multipronged anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease” [Acta Pharmaceutica Sinica B 15 (2025) 5400-5415]

Han Lin, Wenhao Li, Yinying Pu, Kun Zhang et al.

Dec 1, 2025

Acta Pharmaceutica Sinica B

Inflammatory Bowel Disease

article

Author correction to “Cerium single-atom catalysts-armed Lactobacillus reuteri for multipronged anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease” [Acta Pharmaceutica Sinica B 15 (2025) 5400-5415]

Han Lin, Wenhao Li, Yinying Pu, Kun Zhang, Shuang Gao, Shaorong Huang, Qiyue Li, Min Zhou, Yangying Duan, W.Z. Wu

December 1, 2025article en

Abstract

No abstract available for this paper.

Acta Pharmaceutica Sinica BVol. 16(2)

Tongji University (CN), Chinese Academy of Sciences (CN), First Affiliated Hospital of Jiangxi Medical College (CN), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN), Shanghai Institute of Ceramics (CN)

Openalex Percentile: Top 61%

Inflammatory Bowel Disease

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Author correction to “Cerium single-atom catalysts-armed Lactobacillus reuteri for multipronged anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease” [Acta Pharmaceutica Sinica B 15 (2025) 5400-5415] — Han Lin, Wenhao Li, et al. · Acta Pharmaceutica Sinica B (2025) | TGRS Research Map | TGRS